Case Report
Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia
Table 2
alloHCT data outcome.
| | Patient number | Disease status at time of alloHCT | Donor HLA type | Cell dose (CD34 × 106/Kg) | GVHD prophylaxis | Outcome
After alloHCT |
| | 1 | Refractory | 7/8 MRD | 2.56 | Tacrolimus | Relapse
Day +35 | Died of disease progression
Day +65 |
| | 2 | CR | 8/8 MRD | 8.42 | Tacrolimus and MTX | Alive in CR
Day +1354 |
| | 3 | CR | 7/8 MRD | 4.3 | Tacrolimus and MTX | Alive in CR
Day +1145 |
| | 4 | CR | 8/8 MUD | 11.38 | Tacrolimus and MTX | Relapse
Day +75 | Died of disease progression
Day +125 |
|
|
CR: complete remission, HLA: human leukocyte antigen, MRD: matched related donor, MUD: matched unrelated donor, MTX: methotrexate, GVHD: graft versus host disease, alloHCT: allogeneic hematopoietic cell transplantation.
|
